immunogenicity,

immunogenicity of multi-epitope-based vaccine candidates
immunogenicity of fractional-dose vaccine during
fda-the immunogenicity of therapeutic proteins-what you dont
phase 1 studies of the safety and immunogenicity
toll-like receptor 2 dependent immunogenicity of